GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SOTHEMA (CAS:SOT) » Definitions » Future 3-5Y EPS without NRI Growth Rate

SOTHEMA (CAS:SOT) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Apr. 14, 2025)


View and export this data going back to 2005. Start your Free Trial

What is SOTHEMA Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, SOTHEMA's Future 3-5Y EPS without NRI Growth Rate is N/A.


Competitive Comparison of SOTHEMA's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - General subindustry, SOTHEMA's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SOTHEMA's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SOTHEMA's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where SOTHEMA's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

SOTHEMA  (CAS:SOT) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


SOTHEMA Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of SOTHEMA's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


SOTHEMA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SOTHEMA (CAS:SOT) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Traded in Other Exchanges
N/A
Address
Centre de Bouskoura, BP no. 1, Casablanca, MAR
SOTHEMA engages in representation, purchase and sale of pharmaceutical, chemical, health-related, biological, veterinary, plant-based, cosmetic and scented products. The company sells its products in Morocco and overseas.

SOTHEMA Headlines

No Headlines